RANK is an independent biomarker of poor prognosis in estrogen receptor-negative breast cancer and a therapeutic target in patient-derived xenografts

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Biochemistry

Medicine

Cancer Oncology

Internal Medicine

Show all topics

DOI

10.1101/2021.12.13.470911

License

cc-no